Medication Guide App

WPI 2227 (Flutamide 125 mg)

Pill imprint WPI 2227 has been identified as Flutamide 125 mg.

Flutamide is used in the treatment of hirsutism; prostate cancer and belongs to the drug classes antiandrogens, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Flutamide 125 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 2227

Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide
Imprint:
WPI 2227
Strength:
125 mg
Color:
Brown & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiandrogens
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)